Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice
- 29 October 2004
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 12 (1) , 94-97
- https://doi.org/10.1038/sj.cdd.4401523
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Expression of TRAIL (TNF‐related apoptosis‐inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomasThe Journal of Pathology, 2003
- The Arabidopsis Abscisic Acid Response Gene ABI5 Encodes a Basic Leucine Zipper Transcription FactorPlant Cell, 2000
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC GeneScience, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system.The Journal of cell biology, 1992
- Identification and characterization of the familial adenomatous polyposis coli geneCell, 1991
- A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the MouseScience, 1990